| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 203.26B | 228.15B | 232.73B | 225.51B | 170.59B | 163.93B |
| Gross Profit | 27.72B | 31.70B | 22.23B | 15.63B | 13.72B | 16.79B |
| EBITDA | 18.43B | 22.61B | -3.91B | 15.46B | 11.45B | 18.16B |
| Net Income | 8.65B | 10.73B | -21.66B | -6.99B | -1.39B | 2.84B |
Balance Sheet | ||||||
| Total Assets | 203.33B | 178.53B | 181.60B | 187.31B | 193.98B | 163.97B |
| Cash, Cash Equivalents and Short-Term Investments | 15.87B | 19.31B | 18.89B | 10.42B | 7.19B | 3.60B |
| Total Debt | 75.59B | 65.34B | 71.77B | 65.47B | 64.94B | 45.31B |
| Total Liabilities | 127.46B | 112.99B | 126.04B | 118.40B | 118.38B | 91.65B |
| Stockholders Equity | 73.20B | 64.00B | 55.18B | 68.58B | 72.92B | 67.28B |
Cash Flow | ||||||
| Free Cash Flow | -13.90B | 4.90B | 4.63B | 7.66B | -16.67B | 3.57B |
| Operating Cash Flow | 8.27B | 21.08B | 19.49B | 21.96B | 5.71B | 14.58B |
| Investing Cash Flow | -18.97B | -13.15B | -13.26B | -15.19B | -19.27B | -12.21B |
| Financing Cash Flow | 6.51B | -7.34B | 1.28B | -3.51B | 14.89B | -11.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥49.28B | 7.97 | 8.46% | 2.64% | -6.35% | 18.49% | |
70 Outperform | ¥59.92B | 14.59 | ― | 0.99% | -0.83% | -27.20% | |
66 Neutral | ¥42.33B | 50.47 | ― | 5.35% | -6.20% | -64.65% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥37.47B | 4.41 | ― | 5.16% | -11.67% | ― | |
52 Neutral | ¥35.83B | 3.92 | -1.15% | ― | -4.39% | -101.56% | |
47 Neutral | ¥26.77B | -5.63 | ― | 3.33% | -3.91% | -36.53% |